BRKR
Bruker Corporation · Healthcare · Medical - Devices
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 38.48K | $1.97M | n/a | n/a |
| Q2 2026 | 119 | +10 | 81.03M | $4.87B | +18 | −7 |
| Q1 2026 | 111 | -2 | 77.83M | $2.81B | +8 | −11 |
| Q4 2025 | 114 | +1 | 81.30M | $3.83B | +4 | −2 |
| Q3 2025 | 19 | 0 | 49.38M | $1.60B | +3 | −4 |
| Q2 2025 | 17 | +3 | 44.89M | $1.85B | +4 | −1 |
| Q1 2025 | 11 | 0 | 11.41M | $475.20M | +3 | −3 |
| Q4 2024 | 11 | -2 | 10.42M | $610.89M | +1 | −3 |
| Q3 2024 | 12 | -1 | 5.68M | $392.44M | n/a | −1 |
| Q2 2024 | 13 | n/a | 8.60M | $549.04M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Citadel Advisors ✦ | 1.98M | n/a | $126.12M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 2 | Geode Capital Management ✦ (passive) | 1.80M | n/a | $114.88M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 3 | Marshall Wace ✦ | 1.39M | n/a | $88.67M | 0.1% | n/c | 1 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (passive) | 1.05M | n/a | $67.05M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 774.30K | n/a | $49.41M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 6 | Point72 Asset Management ✦ | 571.57K | n/a | $36.47M | 0.1% | n/c | 1 | SEC ↗ |
| 7 | AQR Capital Management ✦ | 555.47K | n/a | $35.44M | 0.1% | n/c | 1 | SEC ↗ ×3 |
| 8 | Millennium Management ✦ | 230.44K | n/a | $14.70M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 143.57K | n/a | $9.16M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Arrowstreet Capital ✦ | 43.57K | n/a | $2.78M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Gotham Asset Management ✦ | 43.34K | n/a | $2.77M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 18.37K | n/a | $1.17M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Fisher Asset Management ✦ | 6.42K | n/a | $409,734 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 339 holders, 136.43M shares, $4.78B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 2.00K sh · $105,740
Officer · 3.47K sh · $197,614
Officer · 2.00K sh · $115,200
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology